ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTI Optibiotix Health Plc

18.00
0.50 (2.86%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 2.86% 18.00 17.50 18.50 18.00 17.50 17.50 242,114 11:30:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.34 16.41M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 17.50p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.41 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.34.

Optibiotix Health Share Discussion Threads

Showing 18426 to 18448 of 147600 messages
Chat Pages: Latest  744  743  742  741  740  739  738  737  736  735  734  733  Older
DateSubjectAuthorDiscuss
04/12/2016
11:07
Does anyone recall if precision microbiome medicine has been mentioned in connection with Optibiotix before Tuesday's RNS?

"The potential for precision microbiome medicine. This is an area of growing scientific and commercial interest with growing evidence that the microbiome plays an important role in how the body metabolises pharmaceutical products, influencing their effectiveness and the potential for adverse reactions."

A couple of articles on precision medicine (both from Nov 2016):



"Making the microbiome part of precision medicine"

"In his 2015 State of the Union, President Barack Obama announced the Precision Medicine Initiative, a far-reaching research effort to develop medical treatments tailored for an individual’s unique genetic makeup, environment and lifestyle. Instead of relying on one-size-fits-all solutions designed to help the largest number of statistically average people, such treatments could leverage advances in genetic testing, molecular engineering and big data analysis to target diseases that are often unique to each patient."



"Microbiome’s Role in Precision Medicine"

"Researchers are mapping the microbiome in an effort to better understand disease treatment and prevention. And even to develop personal treatment plans based on an individual’s specific mix of microorganisms and bacteria."

parob
03/12/2016
16:54
Thanks Diamond - Perhaps, but I am often misquoted or misunderstood (I should proof read I guess), so I thought it best to calm Mazz down before we had another situation that got out of hand again.
elrico
03/12/2016
14:18
There is an article in the The Times today that Parkinson's disease may come about when people have the wrong sort of bacteria in their intestines. Scientists in California have found for the first time that giving mice the bacteria from Parkinson's patients made them fall ill with similar symptoms although mice cannot develop Parkinson's. This is another exciting new avenue for the microbiome.
misconduct
02/12/2016
13:43
Mazz, as I said at the time, you made your agenda very clear when you came on the OPTI BB to ramp OXP. (Interesting that you were targeting 3p but sold at 2.5p, or so you say). So, I don't trust your comments and will ignore them, whether on or off topic. Others can do as they choose.
kipper1960
02/12/2016
13:33
Mazz - I don't know where you get the impression I am attacking you? We had a difference of opinion, that is all. I am happy to stand by my view and wait to see what develops. I stated my logic for deal(s) possibly already signed but not disclosed. I did not suggest I was correct, just an hypothesis. On the voting thing...I NEVER vote anyone down, I much prefer to offer a counter opinion, right or wrong. I only vote up when someone has made an effort that is worthy of a vote.

As a footnote; TW agree with my hypothesis - he thinks a lot of investors have not understood the RNs.

Apologies if you think I have been personal, it is not my intention.

elrico
02/12/2016
13:06
I suspect you accuse me of having a forked tongue because I was right in my interpretation of the latest RNS's? Since my posts from late October onwards I've noticed people marking me down for merely looking at Opti closer than the rose-tinted lot of Elrico and Co. It was clear to me that there would be no deals in November or any signed for that matter. If I deserve a personal attack for stating the obvious then so be it!
mazzstar
02/12/2016
12:29
if you have sold oxp, then that is just as bad, i.e. tipping/ramping a share on here at about the same price you sold at after saying it will hit 3p and then selling shortly afterwards at 2.5, now 1.65. Mazz is not to be trusted. Methinks, he speaks with forked tongue, hopefully no one was foolish to buy in on that poor tip.
neftanikoff
02/12/2016
10:55
If you say so Mazz.
elrico
02/12/2016
10:24
The Parkinson's disease / microbiome story now going mainstream...


Parkinson's disease 'may start in gut'

By James Gallagher

Scientists in California say they have transformed understanding of Parkinson's disease.

Their animal experiments, published in the journal Cell, suggest the brain disorder may be caused by bacteria living in the gut.

The findings could eventually lead to new ways of treating the disease, such as drugs to kill gut bugs or probiotics...

someuwin
02/12/2016
10:24
Elrico you're just miffed I pointed out that the RNS on 26/10 confirmed no imminent deals.
mazzstar
02/12/2016
10:10
neftan thanks for your concern but I bought OXP at 2p and sold at 2.5p
mazzstar
02/12/2016
09:49
i also smell a rat. Or is it a mouse?
kipper1960
02/12/2016
09:23
Mr Gloomy , mazzstar is also a bit miffed as his tip on here , at the time over 2p is now only 1.65p, oh dear, dear dear me.



mazzstar - 25 Oct 2016 - 10:32:32 - 16727 of 17664
3p target for Oxford Pharmascience by the end of the week. I've been waiting for the bounce for weeks.

Oxford Pharmascience (OXP) is worth taking a look at. £21million in cash and the seller appears to be out.

neftanikoff
02/12/2016
09:10
Glancy - I did mean to add you gave my ticker a start this AM. I have family with the Glancy name. I though whom had passed and more importantly, who had OPTI squirrelled away without me knowing?
elrico
02/12/2016
09:08
No tax is liable if inherited and held in an ISA.

Glancy - Apparently, Mazzstar is accusing me and others of talking the share price of OPTI up (ramp - ramping), a common theme which is sometimes justifiable when no reasonable logic or evidence is attached to the commentary. There quite a few investors that commentate on OPTI and while they (and I include me) may get ahead of ourselves, I believe they are HONEST opinions. I my case I have also been critical, but never been accused of de-ramping OPTI (TALKING THE SHARES DOWN). Mazzstar in all probability is a little miffed with me because I think he is wrong about commercial contracts and the timing of them. We will see soon enough.

Tip - Don't go singing about inheriting x times your yearly salary. We have had our belly full of Walter Mitty types. I am not suggesting you are.

Rather name names; click on the icon top right of the thread, "top posts" for a good idea whom to read. It will give you a short cut rather than wade through page after page.

Sorry for your loss - be happy with your gain.

Good luck

elrico
02/12/2016
08:35
Sorry pglancy I reckon I got that one very wrong; it's inheritance tax thatcAIM Shares side-step, isn't it. As I say I live in different jurisdiction; so just pay no attention!
owenmo
02/12/2016
08:31
Well glance it's then a case of third time lucky inasmuch as AIM share gains are exempt of capital gains tax (although as non-UK resident I know nothing of capital transfer tax relativity.) in the circumstances you describe I don't think anyone would discourage you from selling a tranche - just so that you assuredly bank an element of the fortuitous inheritance - only wait, maybe, until we see 100p Michaelmouse notwithstanding!
owenmo
02/12/2016
06:51
I smell a rat
judijudi
01/12/2016
23:13
Owenmo, the shares i inherited are OPTI shares. They were purchased at 23.33p. They have a value several times my yearly salary. I don't know if i should sell them or keep them. I need ramp, ramping explaining.
pglancy
01/12/2016
22:48
Lucky you glance; firstly to have inherited quite a few shares (presupposing, of course that they're of market value!) and secondly to have found yourself, of all places on this BB.
Now a piece of advice to you - which cannot remotely be taken as ramping - is that you sell some of the inherited shares forthwith and buy into OPTI with proceeds.

Taking everything into account there is more than a reasonable chance that in say 9 months' time you'll thank your icky stars that drew you this way.

You can, I propose, engage with an element of AIM stock with inherited money.

Some of us think it would be hard to find a more compelling story - without, needless to say, a crystal ball.

Go for it!

owenmo
01/12/2016
22:41
Ramp? Elevate? OK so Michael mouse, mouse 20, elrico, parob and the boss of the board, someuwin.

Thank you mazzstar.

pglancy
01/12/2016
22:20
The only worthy poster on here who doesn't try ramp at every opportunity is someuwin. And mouse20 is worth following for his detective work.
mazzstar
01/12/2016
21:57
Wow that was quick Judi. I've added elrico an parob. Is the other michaele mouse?
pglancy
Chat Pages: Latest  744  743  742  741  740  739  738  737  736  735  734  733  Older